Lanean...
Left Atrial Thrombosis Despite Dabigatran Therapy
Dabigatran is a novel anticoagulation which has been approved as an alternative to warfarin therapy for non-valvular atrial fibrillation. Use of Dabigatran for approved indications as well as off label use has dramatically increased after Federal Drug Administration (FDA) approval. Our patient had l...
Gorde:
| Argitaratua izan da: | J Atr Fibrillation |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Cardiofront, Inc
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5153238/ https://ncbi.nlm.nih.gov/pubmed/28496880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.891 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|